STOCK TITAN

[Form 4] Genasys Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Mark Culhane, a director of Genasys Inc. (GNSS), was granted 6,411 shares of the company's common stock on 10/01/2025 in lieu of an accrued cash director retainer. After the grant, Mr. Culhane beneficially owned 114,547 shares. The shares were issued based on the cash value of the accrued retainer divided by the closing price on the grant date. The Form 4 filing was signed by an attorney-in-fact on 10/03/2025.

Mark Culhane, direttore di Genasys Inc. (GNSS), ha ricevuto 6,411 azioni ordinarie della società il 10/01/2025 in luogo di un onorario in contanti da direttore maturato. Dopo l'assegnazione, il Sig. Culhane possedeva beneficiariamente 114,547 azioni. Le azioni sono state emesse in base al valore in contanti dell'onorario maturato diviso per il prezzo di chiusura al momento dell'assegnazione. La dichiarazione Form 4 è stata firmata da un procuratore.

Mark Culhane, director de Genasys Inc. (GNSS), recibió 6,411 acciones ordinarias de la compañía el 01/10/2025 en lugar de un honorario en efectivo de director acumulado. Después de la adjudicación, el Sr. Culhane poseía beneficamente 114,547 acciones. Las acciones se emitieron basadas en el valor en efectivo del honorario acumulado dividido por el precio de cierre en la fecha de adjudicación. La presentación del Formulario 4 fue firmada por un apoderado el 03/10/2025.

Mark Culhane, 제너시스 주식회사이사로서, GNSS의 이사 보통주 6,411주를 2025-10-01에 누적 현금 이사 수당 대신 수여받았습니다. 수여 후 Culhane 씨는 실질적으로 114,547주를 소유하게 되었습니다. 이 주식은 누적 수당의 현금가치를 수여일의 종가로 나누어 발행되었습니다. Form 4 제출은 2025-10-03에 대리인이 서명했습니다.

Mark Culhane, directeur de Genasys Inc. (GNSS), a reçu 6 411 actions ordinaires de la société le 01/10/2025 en remplacement d'un salaire de directeur en espèces accumulé. Après l'attribution, M. Culhane détenait bénéficairement 114 547 actions. Les actions ont été émises sur la base de la valeur en espèces du salaire accumulé divisée par le prix de clôture à la date d'attribution. Le dépôt Form 4 a été signé par un mandataire le 03/10/2025.

Mark Culhane, Direktor von Genasys Inc. (GNSS), erhielt am 01.10.2025 6.411 Stammaktien des Unternehmens anstelle einer aufgelaufenen Barvorsteuerung für Direktoren. Nach der Zuteilung besaß Herr Culhane wirtschaftlich 114.547 Aktien. Die Aktien wurden basierend auf dem Barwert der aufgelaufenen Vergütung geteilt durch den Schlusskurs am Tag der Zuteilung ausgegeben. Die Form-4-Einreichung wurde von einem Bevollmächtigten am 03.10.2025 unterzeichnet.

مارك كولهاين، مدير في شركة Genasys Inc. (GNSS)، تلقّى 6,411 سهماً عادياً في الشركة بتاريخ 01/10/2025 بدلاً من أجر المدير النقدي المتراكم. بعد المنحة، امتلك السيد كولهاين بصورة فاعلة 114,547 سهماً. تم إصدار الأسهم بناءً على قيمة النقدية للأجر المتراكم مقسومة على سعر الإغلاق في تاريخ المنحة. تم توقيع تقديم Form 4 من قبل وكيل قانوني في 03/10/2025.

Mark Culhane董事 of Genasys Inc. (GNSS),于 2025/10/01 获得公司普通股 6,411 股,作为累计的董事现金酬金的替代。授予后,Culhane 先生实益拥有 114,547 股。股票的发行基于累计现金酬金的现金价值除以授予日的收盘价。Form 4 的提交由代理律师在 2025/10/03 签署。

Positive
  • None.
Negative
  • None.

Mark Culhane, direttore di Genasys Inc. (GNSS), ha ricevuto 6,411 azioni ordinarie della società il 10/01/2025 in luogo di un onorario in contanti da direttore maturato. Dopo l'assegnazione, il Sig. Culhane possedeva beneficiariamente 114,547 azioni. Le azioni sono state emesse in base al valore in contanti dell'onorario maturato diviso per il prezzo di chiusura al momento dell'assegnazione. La dichiarazione Form 4 è stata firmata da un procuratore.

Mark Culhane, director de Genasys Inc. (GNSS), recibió 6,411 acciones ordinarias de la compañía el 01/10/2025 en lugar de un honorario en efectivo de director acumulado. Después de la adjudicación, el Sr. Culhane poseía beneficamente 114,547 acciones. Las acciones se emitieron basadas en el valor en efectivo del honorario acumulado dividido por el precio de cierre en la fecha de adjudicación. La presentación del Formulario 4 fue firmada por un apoderado el 03/10/2025.

Mark Culhane, 제너시스 주식회사이사로서, GNSS의 이사 보통주 6,411주를 2025-10-01에 누적 현금 이사 수당 대신 수여받았습니다. 수여 후 Culhane 씨는 실질적으로 114,547주를 소유하게 되었습니다. 이 주식은 누적 수당의 현금가치를 수여일의 종가로 나누어 발행되었습니다. Form 4 제출은 2025-10-03에 대리인이 서명했습니다.

Mark Culhane, directeur de Genasys Inc. (GNSS), a reçu 6 411 actions ordinaires de la société le 01/10/2025 en remplacement d'un salaire de directeur en espèces accumulé. Après l'attribution, M. Culhane détenait bénéficairement 114 547 actions. Les actions ont été émises sur la base de la valeur en espèces du salaire accumulé divisée par le prix de clôture à la date d'attribution. Le dépôt Form 4 a été signé par un mandataire le 03/10/2025.

Mark Culhane, Direktor von Genasys Inc. (GNSS), erhielt am 01.10.2025 6.411 Stammaktien des Unternehmens anstelle einer aufgelaufenen Barvorsteuerung für Direktoren. Nach der Zuteilung besaß Herr Culhane wirtschaftlich 114.547 Aktien. Die Aktien wurden basierend auf dem Barwert der aufgelaufenen Vergütung geteilt durch den Schlusskurs am Tag der Zuteilung ausgegeben. Die Form-4-Einreichung wurde von einem Bevollmächtigten am 03.10.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Culhane Mark

(Last) (First) (Middle)
16262 WEST BERNARDO DRIVE

(Street)
SAN DIEGO CA 92127

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Genasys Inc. [ GNSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A(1) 6,411 A $0 114,547 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock granted to the reporting person in lieu of accrued cash retainer for the third and fourth quarters of fiscal year 2025. The number of shares was determined based on the cash value of the accrued retainer divided by the closing price of the Company's common stock on the grant date.
/s/ Cassandra Monteon as attorney-in-fact for Mark Culhane 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Mark Culhane report for GNSS?

The Form 4 reports a grant of 6,411 shares of common stock to Mark Culhane on 10/01/2025 issued in lieu of accrued cash director retainer.

How many GNSS shares does Mark Culhane own after the transaction?

Following the reported transaction, Mark Culhane beneficially owned 114,547 shares of GNSS common stock.

Why were the 6,411 shares issued to the director?

The shares represent payment in lieu of an accrued cash retainer for the third and fourth quarters of fiscal year 2025, with the number set by dividing the cash value by the closing stock price on the grant date.

When was the Form 4 signed and filed?

The Form 4 shows the transaction date as 10/01/2025 and includes a signature by an attorney-in-fact dated 10/03/2025.

What is the reporter's relationship to GNSS?

Mark Culhane is reported as a Director of Genasys Inc.
Genasys Inc

NASDAQ:GNSS

GNSS Rankings

GNSS Latest News

GNSS Latest SEC Filings

GNSS Stock Data

105.66M
41.78M
7.47%
54.52%
1.39%
Scientific & Technical Instruments
Household Audio & Video Equipment
Link
United States
SAN DIEGO